| Views | |
|---|---|
| Evaluating the impact of bevacizumab as a targeted therapy in combination with standard chemotherapy on disease progression and treatment outcomes in ovarian cancer | 16 |
| September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | |
|---|---|---|---|---|---|---|---|
| Evaluating the impact of bevacizumab as a targeted therapy in combination with standard chemotherapy on disease progression and treatment outcomes in ovarian cancer | 0 | 0 | 14 | 1 | 0 | 1 | 0 |
| Views |
|---|
| Views | |
|---|---|
| United States | 4 |
| Ireland | 3 |
| Russia | 2 |
| Belarus | 1 |
| Canada | 1 |
| South Africa | 1 |
| Views | |
|---|---|
| Menlo Park | 2 |
| Moscow | 2 |
| Buffalo | 1 |
| Johannesburg | 1 |
| Minsk | 1 |
| Ottawa | 1 |
| San Diego | 1 |